Novo Nordisk A S
NVO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000353278
No open-market purchases or sales by Novo Nordisk A S insiders were filed in the last 90 days; 1,361 institutions reported holding it in 13F filings for Q2 2026, worth $15.7B in total; superinvestors Markel Group and Maverick Capital hold it.
Other share classesNONOF
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +93 vs. previous quarter
- 1,361
- 13F valueReported value at the end of Q2 2026
- $15.7B
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Financials
See financial statementsFrom SEC filings, in DKK.
- Revenue, FY2025
- DKK 309.1B
- +6.4% year over year
- Net income, FY2025
- DKK 102.4B
- +1.4% year over year
- Free cash flow, FY2025
- DKK 59.0B
- −20.1% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 37.4M
- Shares sold short
- Change
- +5.81M
- +18.4% vs. previous
- Days to cover
- 3.11
- At average daily volume
Superinvestors holding NVO, Q2 2026
Go to the superinvestors tab2 superinvestors report holding Novo Nordisk A S on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Novo Nordisk A S insiders from Form 4, newest first.
No open-market purchases or sales by Novo Nordisk A S insiders are on file.
Top 10 13F holders, Q2 2026
See all 1,361 holdersThe largest institutional positions in Novo Nordisk A S at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dodge & Cox | 20,397,110 | $977.8M | 0.51% | +1,063,360+5.5% | Added |
| Loomis Sayles & Co L P | 18,594,352 | $891.4M | 1.12% | +1,577,037+9.3% | Added |
| Franklin Resources Inc | 13,041,109 | $625.2M | 0.14% | −3,042,370−18.9% | Reduced |
| Price T Rowe Associates Inc | 11,704,719 | $561.1M | 0.06% | +644,039+5.8% | Added |
| Morgan Stanley | 11,659,869 | $559.0M | 0.03% | +790,669+7.3% | Added |
| Bank of America Corp | 11,176,712 | $535.8M | 0.03% | +407,013+3.8% | Added |
| Capital International Investors | 9,721,180 | $467.6M | 0.10% | −2,074,670−17.6% | Reduced |
| Folketrygdfondet | 9,522,383 | $456.5M | 9.85% | +441,563+4.9% | Added |
| Goldman Sachs Group Inc | 9,180,490 | $440.1M | 0.05% | +4,059,453+79.3% | Added |
| Fisher Asset Management, LLC | 8,324,948 | $399.1M | 0.12% | −696,155−7.7% | Reduced |
Politician trades
All politician trades in NVO14 members of Congress reported 34 trades in Novo Nordisk A S since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Sep 25, 2026 |  Kevin Hern House · OK | Sell (partial) | $1K-$15K |
| Sep 25, 2026 | Kevin Hern House · OK | Sell | $1K-$15K |
| Sep 17, 2026 |  Scott Franklin House · FL | Buy | $1K-$15K |
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $15K-$50K |
| Nov 21, 2025 |  Lisa C. McClain House · MI | Sell | $1K-$15K |
House · OK · Sep 25, 2026
Sell (partial)$1K-$15K
House · OK · Sep 25, 2026
Sell$1K-$15K
House · FL · Sep 17, 2026
Buy$1K-$15K
Senate · OK · Jul 21, 2026
Buy$15K-$50K
House · MI · Nov 21, 2025
Sell$1K-$15K